Megavog MF 0.3/500 Tablet SR
Marketer
Aristo Pharmaceuticals Pvt Ltd
Salt Composition
Metformin (500mg) + Voglibose (0.3mg)
Overview Megavog MF 0.3/500 Tablet SR
Diabeva Duo 0.3/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Diabeva Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Potential side effects, such as nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes, are generally transient and self-limiting. Persistent or concerning side effects necessitate medical consultation. Your doctor can offer strategies to manage or treat bothersome side effects. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician prior to commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are recommended.
Primary Ingredients of Megavog MF 0.3/500 Tablet SR
There is no text provided to rephrase.
Uses of Megavog MF 0.3/500 Tablet SR
Managing type 2 diabetes
Major Benefits of Megavog MF 0.3/500 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Megavog MF 0.3/500 Tablet SR whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Megavog MF 0.3/500 Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Megavog MF 0.3/500 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Megavog MF 0.3/500 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
How Megavog MF 0.3/500 Tablet SR works:
Megavog MF 0.3/500 Extended-Release Tablets contain a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Megavog MF 0.3/500 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Megavog MF 0.3/500 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against the risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Megavog MF 0.3/500 tablets are likely unsafe for breastfeeding mothers. Scant evidence from humans indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingSAFE
The extended-release Megavog MF 0.3/500 tablet typically doesn't impair driving ability. Nevertheless, individuals using this medication concurrently with other blood-sugar-lowering drugs like sulfonylureas, insulin, or repaglinide should be aware of the potential for low blood sugar.
KidneyCAUTION
Patients with kidney impairment should use Megavog MF 0.3/500 SR tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. For individuals with severe kidney disease, Megavog MF 0.3/500 SR tablets are contraindicated. Routine kidney function monitoring is advised during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Megavog MF 0.3/500 Tablet SR use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Megavog MF 0.3/500 Tablet SR :
Should you forget to take a Megavog MF 0.3/500 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Megavog MF 0.3/500 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently